As of December 15, 2025, Kukje Pharma Co Ltd (002720.KS) reports a ROA (Return on Assets) of 3.14%.
ROA (Return on Assets) evaluates how effectively a company turns its assets into profits, showcasing resource utilization.
Historical Trend of Kukje Pharma Co Ltd's ROA (Return on Assets)
Over recent years, Kukje Pharma Co Ltd's ROA (Return on Assets) has shown a stable trend. The table below summarizes the historical values:
| Date | ROA (Return on Assets) |
|---|---|
| 2024-12-31 | 3.14% |
| 2023-12-31 | -5.15% |
| 2022-12-31 | 2.60% |
| 2021-12-31 | -1.12% |
| 2020-12-31 | 1.51% |
This slight upward trend highlights how Kukje Pharma Co Ltd manages its efficiency in using assets to generate earnings over time.
Comparing Kukje Pharma Co Ltd's ROA (Return on Assets) to Peers
To better understand Kukje Pharma Co Ltd's position, it's useful to compare its ROA (Return on Assets) against industry peers. Below are selected comparisons:
| Company | ROA (Return on Assets) |
|---|---|
| Kukje Pharma Co Ltd (002720.KS) | 3.14% |
| Humedix Co Ltd (200670.KQ) | 15.72% |
| Theragen Etex Co Ltd (066700.KQ) | 10.78% |
| Dai Han Pharm Co Ltd (023910.KQ) | 10.41% |
| High Tech Pharm Co Ltd (106190.KQ) | 9.79% |
| Sam-A Pharm Co Ltd (009300.KQ) | 8.88% |
Compared to its competitors, Kukje Pharma Co Ltd's ROA (Return on Assets) is about average compared to peers, indicating typical asset efficiency for the industry.